Gene Therapy Manufacturing

UK Cell and Gene Therapy Production Sites Double in UK’s Bid to Compete in Industry

Sep 25, 2019 | Advanced Therapy Medicinal Products, Cell Therapy, Gene Therapy, Gene Therapy Manufacturing

The UK’s Cell and Gene Catapult (CGT Catapult) completed six additional production modules in a bid for the UK to remain competitive in the booming cell and gene therapy drug development business. The first six clean room at capacity due to high demand at the...

Catalent Acquires Paragon Biosciences for $1.2 Billion: Race for Gene Therapy MFG Capacity

Apr 17, 2019 | Gene Therapy, Gene Therapy Manufacturing, M&A

Lisa Urquhart reports that with the growing gene therapy development pipeline comes the need for manufacturing capacity. Will biopharma firms buy or build? Buy will often be the answer when feasible. The $1.2 billion all cash deal represents a considerable premium....

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

159 WEST BROADWAY SUITE 200
SALT LAKE CITY, UT 84101

UK Cell and Gene Therapy Production Sites Double in UK’s Bid to Compete in Industry

Catalent Acquires Paragon Biosciences for $1.2 Billion: Race for Gene Therapy MFG Capacity

Pin It on Pinterest